# Validation Study of Uromonitor in High Risk Microhematuria Patients

> **NCT05344937** · — · UNKNOWN · sponsor: **Clinica Universidad de Navarra, Universidad de Navarra** · enrollment: 343 (estimated)

## Conditions studied

- Bladder Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05344937
- **Lead sponsor:** Clinica Universidad de Navarra, Universidad de Navarra
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-05-02
- **Primary completion:** 2023-12-31
- **Final completion:** 2024-05-01
- **Target enrollment:** 343 (ESTIMATED)
- **Last updated:** 2022-05-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05344937

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05344937, "Validation Study of Uromonitor in High Risk Microhematuria Patients". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05344937. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*